Title: Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
Description: Report highlights key progress and achievements across three pillars: access to medicines, R&D innovation, and product quality and patient safety 430,000 patients have been treated with Samsung Bioepis’ biosimilars across 40 countries in 2023 In 10 countries,…
Content: Author of the article:
Article content
<ul><li>Report highlights key progress and achievements across three pillars: access to medicines, R&amp;D innovation, and product quality and patient safety<… [+8817 chars]